Life Spine announced that the company will launch FS3 Posterior MIS Screw System in August. The company received marketing clearance for FS3 Posterior MIS Screw System from US FDA in this month.
FS3 Posterior MIS Screw System allows for fast, reliable, and reproducible access and implantation with minimal exposure and tissue dissection. It offers cannulated wire guided Minimally Invasive Surgery implants and instrumentation to accommodate a spectrum of patient pathologies through a percutaneous or open approach.
Michael S. Butler, Life Spine’s President and CEO stated, This is the first of many new minimally invasive innovations that Life Spine is bringing to market over the next six months. In addition to our already diverse product offering, the FS3 posterior MIS screw system marks our fourteenth product to market and further strengthens our position as an engineering centric operation focused on bringing surgeon concepts to life.